NO20055695L - Tiadiazinforbindelser og anvendelse derav som positive AMPA-reseptormodulatorer - Google Patents
Tiadiazinforbindelser og anvendelse derav som positive AMPA-reseptormodulatorerInfo
- Publication number
- NO20055695L NO20055695L NO20055695A NO20055695A NO20055695L NO 20055695 L NO20055695 L NO 20055695L NO 20055695 A NO20055695 A NO 20055695A NO 20055695 A NO20055695 A NO 20055695A NO 20055695 L NO20055695 L NO 20055695L
- Authority
- NO
- Norway
- Prior art keywords
- branched
- linear
- compounds
- alkyl group
- hydrogen atom
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0305448A FR2854634B1 (fr) | 2003-05-05 | 2003-05-05 | Nouveaux derives de thiadiazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
| PCT/FR2004/001070 WO2004099217A1 (fr) | 2003-05-05 | 2004-05-04 | Derives de thiadiazine et leur utilisation comme modulateurs positifs des recepteurs ampa |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20055695L true NO20055695L (no) | 2005-12-01 |
Family
ID=33306157
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20055695A NO20055695L (no) | 2003-05-05 | 2005-12-01 | Tiadiazinforbindelser og anvendelse derav som positive AMPA-reseptormodulatorer |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US7476668B2 (fr) |
| EP (1) | EP1620441A1 (fr) |
| JP (1) | JP4461139B2 (fr) |
| KR (1) | KR100741235B1 (fr) |
| CN (1) | CN100363368C (fr) |
| AR (1) | AR044245A1 (fr) |
| AU (1) | AU2004236005B2 (fr) |
| BR (1) | BRPI0410002A (fr) |
| CA (1) | CA2524377C (fr) |
| EA (1) | EA009240B1 (fr) |
| FR (1) | FR2854634B1 (fr) |
| GE (1) | GEP20084318B (fr) |
| HK (1) | HK1088327A1 (fr) |
| MA (1) | MA27732A1 (fr) |
| MX (1) | MXPA05011823A (fr) |
| MY (1) | MY136694A (fr) |
| NO (1) | NO20055695L (fr) |
| NZ (1) | NZ543214A (fr) |
| UA (1) | UA80046C2 (fr) |
| WO (1) | WO2004099217A1 (fr) |
| ZA (1) | ZA200508660B (fr) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2404605B1 (fr) | 2004-08-25 | 2015-04-22 | Essentialis, Inc. | Formulations pharmaceutiques d'activateurs de canaux potassiques ATP et leurs utilisations |
| JP5543110B2 (ja) * | 2006-01-05 | 2014-07-09 | エッセンシャリス，インク． | カリウムａｔｐチャネルオープナの塩およびその使用 |
| US20110218190A1 (en) * | 2008-11-10 | 2011-09-08 | The Regents Of The University Of California | Therapeutic uses of ampa receptor modulators for treatment of motor dysfunction |
| DK2603513T3 (da) | 2010-08-10 | 2020-06-15 | Takeda Pharmaceuticals Co | Heterocyklisk forbindelse og anvendelse deraf som AMPA-receptorpositiv allosterisk modulator |
| JP5901365B2 (ja) * | 2012-03-12 | 2016-04-06 | 株式会社トクヤマ | イミダート化合物の製造方法 |
| AU2014277952A1 (en) | 2013-06-13 | 2016-01-28 | Veroscience Llc | Compositions and methods for treating metabolic disorders |
| PL3321252T3 (pl) | 2015-07-06 | 2021-04-06 | Public University Corporation Yokohama City University | Nowy związek, który specyficznie wiąże się z receptorem AMPA |
| JP6241974B1 (ja) | 2017-01-11 | 2017-12-06 | 公立大学法人横浜市立大学 | 霊長類生体の脳内ａｍｐａ受容体のイメージング方法、プログラム、及びスクリーニング方法 |
| US10680583B1 (en) * | 2019-02-26 | 2020-06-09 | Xilinx, Inc. | Control circuit for and method of controlling an operation of an integrated circuit device |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3733409A (en) * | 1969-05-20 | 1973-05-15 | Schering Corp | Method of treating hypertension using thieno (1,2,4) thiadiazines |
| AU4345297A (en) * | 1996-09-17 | 1998-04-14 | Regents Of The University Of California, The | Benzothiadiazide derivatives and their use as allosteric up-modulators of the ampa receptor |
| EP1000066A1 (fr) * | 1997-07-16 | 2000-05-17 | Novo Nordisk A/S | Derives de 1,2,4-thiadiazine fusionnee, leur preparation et utilisation |
| RU2214405C2 (ru) * | 1998-02-18 | 2003-10-20 | НьюроСёрч А/С | Новые соединения и их применение в качестве положительных модуляторов амра-рецепторов |
| FR2801587B1 (fr) * | 1999-11-30 | 2002-01-11 | Adir | Nouveaux derives de benzothiadiazines, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
-
2003
- 2003-05-05 FR FR0305448A patent/FR2854634B1/fr not_active Expired - Fee Related
-
2004
- 2004-04-05 UA UAA200511454A patent/UA80046C2/uk unknown
- 2004-04-30 MY MYPI20041647A patent/MY136694A/en unknown
- 2004-05-04 AR ARP040101515A patent/AR044245A1/es unknown
- 2004-05-04 ZA ZA200508660A patent/ZA200508660B/en unknown
- 2004-05-04 MX MXPA05011823A patent/MXPA05011823A/es active IP Right Grant
- 2004-05-04 BR BRPI0410002-6A patent/BRPI0410002A/pt not_active IP Right Cessation
- 2004-05-04 JP JP2006505830A patent/JP4461139B2/ja not_active Expired - Fee Related
- 2004-05-04 GE GEAP20049092A patent/GEP20084318B/en unknown
- 2004-05-04 EA EA200501696A patent/EA009240B1/ru not_active IP Right Cessation
- 2004-05-04 KR KR1020057020817A patent/KR100741235B1/ko not_active IP Right Cessation
- 2004-05-04 AU AU2004236005A patent/AU2004236005B2/en not_active Ceased
- 2004-05-04 NZ NZ543214A patent/NZ543214A/en not_active IP Right Cessation
- 2004-05-04 US US10/555,743 patent/US7476668B2/en not_active Expired - Fee Related
- 2004-05-04 EP EP04742632A patent/EP1620441A1/fr not_active Withdrawn
- 2004-05-04 CA CA2524377A patent/CA2524377C/fr not_active Expired - Fee Related
- 2004-05-04 WO PCT/FR2004/001070 patent/WO2004099217A1/fr active Application Filing
- 2004-05-04 CN CNB200480014886XA patent/CN100363368C/zh not_active Expired - Fee Related
-
2005
- 2005-10-21 MA MA28567A patent/MA27732A1/fr unknown
- 2005-12-01 NO NO20055695A patent/NO20055695L/no not_active Application Discontinuation
-
2006
- 2006-08-10 HK HK06108870A patent/HK1088327A1/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| FR2854634A1 (fr) | 2004-11-12 |
| GEP20084318B (en) | 2008-03-10 |
| FR2854634B1 (fr) | 2005-07-08 |
| US7476668B2 (en) | 2009-01-13 |
| CA2524377C (fr) | 2010-08-24 |
| AR044245A1 (es) | 2005-09-07 |
| CA2524377A1 (fr) | 2004-11-18 |
| KR20060006830A (ko) | 2006-01-19 |
| NZ543214A (en) | 2009-02-28 |
| EA200501696A1 (ru) | 2006-06-30 |
| UA80046C2 (en) | 2007-08-10 |
| MY136694A (en) | 2008-11-28 |
| AU2004236005B2 (en) | 2010-01-21 |
| AU2004236005A1 (en) | 2004-11-18 |
| ZA200508660B (en) | 2007-01-31 |
| HK1088327A1 (en) | 2006-11-03 |
| WO2004099217A1 (fr) | 2004-11-18 |
| US20070004709A1 (en) | 2007-01-04 |
| BRPI0410002A (pt) | 2006-04-25 |
| JP2006525292A (ja) | 2006-11-09 |
| EP1620441A1 (fr) | 2006-02-01 |
| MA27732A1 (fr) | 2006-01-02 |
| MXPA05011823A (es) | 2006-05-25 |
| CN100363368C (zh) | 2008-01-23 |
| KR100741235B1 (ko) | 2007-07-19 |
| EA009240B1 (ru) | 2007-12-28 |
| JP4461139B2 (ja) | 2010-05-12 |
| CN1798750A (zh) | 2006-07-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20055695L (no) | Tiadiazinforbindelser og anvendelse derav som positive AMPA-reseptormodulatorer | |
| IL164487A0 (en) | 3-Heteroaryl substituted 5-methyloxymethyl isoxazolines used as herbicides | |
| CA2565660A1 (fr) | Composes aryl- ou heteroarylamides ortho-substitues | |
| WO2005105732A8 (fr) | Composes methylaryl- ou heteroarylamides substitues | |
| CY1107008T1 (el) | Παραγωγο βενζιμιδαζολης και χρηση ως ανταγωνιστου υποδοχεα aii | |
| WO2008108386A1 (fr) | Composition pharmaceutique | |
| CA2536870A1 (fr) | Composes de phenyle ou de pyridyle amide utiles comme antagonistes de la prostaglandine e2 | |
| TW200510381A (en) | Novel 2-pyridinecarboxamide derivatives | |
| NO20076006L (no) | Acetylenderivater | |
| EP1642880A4 (fr) | Inhibiteur de proteines de la famille hsp90 | |
| NO20072409L (no) | Substituerte n-sulfonylaminobenzyl-2-fenoksy acetamid-forbindelser | |
| NO20071008L (no) | Fremgangsmate for fremstilling av N-piperidino-1,5-difenylpyrazol-3-karboksamidderivater | |
| EA201071012A1 (ru) | Производные азетидинов, способ их получения и применение их в терапии | |
| DE60223339D1 (de) | Durch bicyclische aminogruppen substituierte verbindungen | |
| MX2010010471A (es) | Derivado de tetrahidroisoquinolina novedoso. | |
| HK1077070A1 (en) | Oligosaccharide derivative | |
| NO20070972L (no) | Benzyloksyderivater som MAOB-inhibitorer | |
| NO20065323L (no) | 6-substituerte pyridoindolonderivater, fremstilling og anvendelse derav | |
| MY134226A (en) | 1,2-dihydropyrazol-3-ones which control inflammatory cyctokines | |
| MX2010008740A (es) | Derivado de 3,8-diaminotetrahidroquinolina. | |
| ES2195016T3 (es) | Medicamento contra la trombocitopenia. | |
| BRPI0516549A (pt) | derivados de ácido [2-(8,9-dioxo-2,6-diazabiciclo[5.2.0]non-1(7)-en-2-il)alquil ]fosfÈnico e métodos para sua fabricação | |
| MY142362A (en) | Pharmaceutical composition for promoting angiogenesis | |
| MX2008002753A (es) | Derivados de piridazinona utilizados para el tratamiento de dolor. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |